SHELLEY ALBERTSON: Open Payments
NPI 1952012692 · FAYETTEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$941 in 33 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $941
Food & beverage: $752Education: $189
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 5 | $190 |
| GENZYME CORPORATION | 8 | $167 |
| Janssen Biotech, Inc. | 2 | $106 |
| ABBVIE INC. | 4 | $104 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Arcutis Biotherapeutics, Inc. | 3 | $59 |
| Almirall LLC | 2 | $57 |
| Galderma Laboratories, L.P. | 2 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $23 |
Products named: DUPIXENT, TREMFYA, RINVOQ, Zoryve, Seysara, NEMLUVIO, SKYRIZI, INTERSTIM.
Industry payments across GA — which companies pay providers there.
